Graham K. Cooper, CFO and Treasurer at Orexigen Therapeutics, Inc. (OREX), sold 4,000 shares at $14.85 ($59K) on 2007-11-20, disclosed to the SEC on 2007-11-21.
Scheduled sale ($59k) by CFO and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 445 | $6K | 10.9% |
| 2 | $14.60 | 444 | $6K | 11.0% |
| 3 | $14.70 | 444 | $7K | 11.1% |
| 4 | $14.75 | 889 | $13K | 22.2% |
| 5 | $14.80 | 444 | $7K | 11.1% |
| 6 | $14.85 | 976 |
| $14K |
| 24.6% |
| 7 | $14.86 | 88 | $1K | 2.2% |
| 8 | $14.91 | 270 | $4K | 6.8% |
| Total | $14.74 avg | 4,000 | $59K | 100% |
| Filing → |
| RCPT | SELL | 2014-09-17 | $3.1M | — | Filing → |
| OREX | SELL | 2009-12-23 | $678K | — | Filing → |
| OREX | SELL | 2009-12-23 | $147K | — | Filing → |